Hospital Vein Visualization ROI Calculator

Estimate the annual savings and payback of projection vein illumination for your facility. Every assumption is editable, so you can model your own numbers. Tap "Definitions & sources" below the calculator to see input definitions and default data sources.

Section 1: Facility information

Number of beds

Average occupancy rate (%)

% of patients requiring IV placement

Average IV change cycle (days)

Section 2: Stick reduction savings

Current avg attempts per IV placement (without vein finder)

Projected avg attempts (with vein finder)

Operational cost per stick attempt ($)

Section 3: Nursing efficiency and delay costs

Current % of IVs requiring nurse escalation (without vein finder)

Projected % of IVs requiring escalation (with vein finder)

Avg procedural delay per escalation (minutes)

Avg fully-loaded nursing cost per hour ($)

Section 4: PICC line avoidance

Current % of IVs escalating to PICC (without vein finder)

% of escalated PICCs deemed unnecessary

% of unnecessary PICCs avoided by vein finder use

Average cost per PICC insertion ($)

Section 5: CLABSI prevention

CLABSI rate per PICC (cumulative %)

Cost per CLABSI event, unreimbursed ($)

Section 6: Device investment

Beds per device (coverage ratio)

Cost per device ($)

Net first-year savings

First-year ROI

Break-even (months)

Annual IV placements	0
Needle sticks avoided / yr	0
Savings: stick reduction	$0
Savings: nursing efficiency	$0
Savings: PICC avoidance	$0
Savings: CLABSI prevention	$0
Total annual savings	$0
Device investment (0 units)	$0

Send yourself the full results to see the complete breakdown

Send Me My Full Results

Estimates only, based on conservative published assumptions and the values you enter; not a guarantee of outcomes. Confirm the device price with NextVein and edit any field to model your facility. See our evidence for vein visualization for the full references.

▸ Definitions & sources (tap to expand)

What each input means and where the default assumption comes from. Bracketed references map to the full NextVein ROI business case.

Input	Definition & source
Section 1: Facility information
Number of beds	Your facility or department bed count.
Average occupancy rate (%)	National avg ~64%; teaching hospitals 85-95% [Ref 15].
% of patients requiring IV placement	Horattas 2001: ~90% [Ref 15]; Keleekai 2017: ≥80% [Ref 2].
Average IV change cycle (days)	INS recommends a 72-96 hr change cycle [Ref 1].
Section 2: Stick reduction savings
Current avg attempts per IV placement (without vein finder)	National avg 2.18-2.4 (LaRue 2000 [Ref 3]; Keleekai 2017 [Ref 2]).
Projected avg attempts (with vein finder)	Hess 2010 [Ref 5]; SSM Cardinal Glennon data: ~1.18.
Operational cost per stick attempt ($)	Santolucito 2001: $32 operational cost per attempt [Ref 6].
Section 3: Nursing efficiency and delay costs
Current % of IVs requiring nurse escalation (without vein finder)	Witting 2012: 8-59% DIVA incidence; 28% moderate [Ref 13].
Projected % of IVs requiring escalation (with vein finder)	Estimate based on improved first-stick success.
Avg procedural delay per escalation (minutes)	Davis et al. 2021: significant delays across care metrics [Ref 4].
Avg fully-loaded nursing cost per hour ($)	Includes salary, benefits, and overhead for an RN.
Section 4: PICC line avoidance
Current % of IVs escalating to PICC (without vein finder)	Varies by facility; 2% is conservative [Ref 7].
% of escalated PICCs deemed unnecessary	MAGIC: DVA-driven PICCs are often inappropriate [Ref 8].
% of unnecessary PICCs avoided by vein finder use	Literature: ultrasound-guided PIV prevents 74-85% of DIVA central lines.
Average cost per PICC insertion ($)	Bedside ~$300; IR ~$800-$1,000 [Ref 9]; midpoint used.
Section 5: CLABSI prevention
CLABSI rate per PICC (cumulative %)	Literature range 2-5%; 3% is mid-range [Ref 10, 12].
Cost per CLABSI event, unreimbursed ($)	AHRQ 2017: $48,108 avg; range $18K-$90K+ [Ref 10]. A CMS non-reimbursed "never event."
Section 6: Device investment
Beds per device (coverage ratio)	1 device per 4 beds ensures availability at the bedside.
Cost per device ($)	Enter your quoted device price.

Why hospitals choose NextVein

Affordable alternative to other systems such as AccuVein, without sacrificing performance.
US-based service and support, backed by a 3-year Total Protection Plan.
Request a free evaluation trial on your own patients before you commit.

Frequently asked questions

Why does first-attempt IV success matter?

Every failed IV stick costs more than a moment of discomfort. Peripheral IV insertion is the most common invasive procedure in hospitals, yet first-attempt success for general nursing staff ranges from just 44% to 77% (Keleekai 2017). Each missed attempt adds supply and labor cost, and after two failed sticks the Infusion Nurses Society standard requires escalation, which can cascade into unnecessary PICC lines and central-line infection risk.

How much does difficult IV access cost a hospital?

More than most teams realize. Each failed attempt adds roughly $28 to $35 in supplies and labor (Santolucito 2001), and difficult access is a leading driver of unnecessary PICC lines at $300 to $1,000 each. One study estimated the annual difficult-venous-access burden in a single emergency department at up to $890,095 (Gala 2024).

What is the ROI of a vein visualization system?

It depends on your volumes, but savings come from fewer needle sticks, less nursing time lost to escalations, fewer unnecessary PICC lines, and avoided CLABSI costs. In a conservative 100-bed model, projected annual savings can exceed the device cost within roughly two months. Enter your own numbers in the calculator above.

How many IV attempts does vein visualization save?

Published studies show projection and near-infrared vein visualization can reduce the average number of attempts from about 2.3 to 1.18, roughly 49% (LaRue 2000; Hess 2010), with the strongest results in pediatric and difficult-access patients. Individual results vary.

How does it affect PICC use and CLABSI risk?

When peripheral vein access succeeds sooner, fewer patients are escalated to PICC lines placed solely due to difficult access, which the MAGIC guidelines discourage (Chopra 2015). Fewer unnecessary PICCs means fewer opportunities for central-line-associated bloodstream infection, a CMS non-reimbursed event that AHRQ estimates at $48,108 per case.

Is NextVein a more affordable alternative to AccuVein?

NextVein provides hospital-grade projection vein visualization at a lower price than other systems, backed by US-based service and support and a 3-year Total Protection Plan. Many buyers evaluate it as an affordable alternative to AccuVein.

Can we try it before buying?

Yes. NextVein offers a free evaluation opportunity so your team can use it on your own patients before committing. Contact us to arrange a trial and a personalized ROI review.